Pharmacodynamic parameters of immunosuppressive drugs are not correlated with age, duration of dialysis, percentage of lymphocytes or lymphocyte stimulation index in renal transplant recipients

Biological and Pharmaceutical Bulletin

Volumn 31, Issue 11, 2008, Pages 2146-2149

  Sugiyama, Kentaro ^a   Isogai, Kazuya ^a   Toyama, Akira ^a   Satoh, Hiroshi ^a   Saito, Kazuhide ^b   Nakagawa, Yuki ^b   Tasaki, Masayuki ^b   Takahashi, Kota ^b   Saito, Noriko ^b   Hirano, Toshihiko ^c  

^a NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^c TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Aging; Immunosuppressive therapy; Lymphocyte immunosuppressant sensitivity test; Renal transplantation

Indexed keywords

CYCLOSPORIN A; MERCAPTOPURINE; METHYLPREDNISOLONE; MIZORIBINE; MYCOPHENOLIC ACID; TACROLIMUS;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CLINICAL ARTICLE; DIALYSIS; FEMALE; GRAFT RECIPIENT; HUMAN; IC 50; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTE TRANSFORMATION; MALE; PHARMACODYNAMICS; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; AGING; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOASSAY; IMMUNOSUPPRESSIVE AGENTS; INHIBITORY CONCENTRATION 50; KIDNEY TRANSPLANTATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; RENAL DIALYSIS; TIME FACTORS; YOUNG ADULT;

EID: 55549129627     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.31.2146     Document Type: Article

References (14)

1. Hirano T., Oka K., Takeuchi H., Sakurai E., Matsuno N., Tamaki T., Kozaki M., Transplantation, 57, 1341-1348 (1994).
2. Sugiyama K., Arakawa K., Satoh H., Saito K., Takahashi K., Saito N., Hirano T., J. Immunoassay Immunochem., 27, 195-205 (2006).
3. Sugiyama K., Satoh H., Saito K., Takahashi K., Saito N., Hirano T., Transpl. Int., 18, 590-595 (2005).
4. Sugiyama K., Satoh H., Hirano T., J. Pharm. Pharmacol., 55, 393-398 (2003).
5. Sugiyama K., Kawada T., Satoh H., Hirano T., J. Pharm. Pharmacol., 53, 727-733 (2001).
6. Takeuchi H., Hirano T., Oka K., Mizumoto K., Akashi T., Sakurai E., Degawa T., Uchiyama M., Kozaki K., Matsuno N., Nagao T., Kozaki M., Transplant. Proc., 30, 36-39 (1998).
7. Hirano T., Int. Immunopharmacol., 7, 3-22 (2006).
8. Hearing S. D., Norman M., Probert C. S., Haslam N., Dayan C. M., Gut, 45, 382-388 (1999).
9. Dudley J., Truman C., McGraw M., Tizard J., Haque G., Bradley B., Nephrol. Dial. Transplant., 18, 403-410 (2003).
10. Plosker G. L., Foster R. H., Drugs, 59, 323-389 (2000).
11. Anthony C. A., "The Molecular Biology of Immunosuppression," ed. by Thompson A. W., John Wiley & Sons, Ltd., N.Y., 1992, pp. 181-209.
12. Joel G. H., Alfred G. G., Lee E. L., "Goodman & Gilman's The Pharmacological Basis of Therapeutics," 9th ed., 1995.
13. Di Pietro R., Miscia S., Cataldi A., Rana R., Br. J. Haematol., 111, 1209-1214 (2000).
14. Schindowski K., Frohlich L., Maurer K., Muller W. E., Eckert A., Mech. Ageing Dev., 123, 375-390 (2002).